Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) were down 27% during mid-day trading on Wednesday . The stock traded as low as GBX 7.38 ($0.10) and last traded at GBX 9.85 ($0.13). Approximately 62,044 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 236,416 shares. The stock had previously closed at GBX 13.50 ($0.18).
Celadon Pharmaceuticals Stock Performance
The firm has a market cap of £7.97 million, a P/E ratio of -1.63 and a beta of -0.26. The company has a debt-to-equity ratio of 196.67, a quick ratio of 6.97 and a current ratio of 1.92. The business’s 50-day simple moving average is GBX 18.34 and its 200 day simple moving average is GBX 23.13.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- What Is WallStreetBets and What Stocks Are They Targeting?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Quiet Period Expirations Explained
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
